Apparently, in the setting of breast cancer metastasis, systemic Angpt-2-dependent mechanisms may be more important than systemic vascular endothelial growth factor (VEGF)-dependent mechanisms, even though the latter is of importance in patients with breast cancer (Thielemann et al., 2010). The gene discussed is VEGFA; the disease is breast cancer.